Valuation (14%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -4.34 | 3.77 |
| PEG Ratio (TTM) | -0.04 | 1.14 |
| P/S Ratio (TTM) | 0.53 | 1.36 |
| P/B Ratio (TTM) | 6.82 | 2.25 |
| P/FCF Ratio (TTM) | -0.58 | 17.70 |
| Price to 5YR AVG Earnings Ratio | N/A | -89.67 |
| Price to 5YR AVG FCF Ratio | N/A | 17.93 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -65.40% | 1.31% |
| ROE (TTM) | -226.92% | 17.99% |
| Net Profit Margin (TTM) | -82.52% | 2.12% |
| ROIC 5YR AVG | N/A | 19.17% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | N/A | 325.20% | N/A |
| Revenue | N/A | -2.96% | N/A |
| Net Income | N/A | 260.37% | N/A |
| Cash Flow | N/A | -139.17% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.76 | 1.21 |
| Quick Ratio (TTM) | 1.76 | 1.17 |
| D/E Ratio (TTM) | 0.84 | 1.02 |
| Interest Coverage (TTM) | -19.10 | 4.84 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | N/A | 2.16 |
| LTL to 5YR AVG FCF | N/A | 5.46 |
| Shares Outstanding Growth 5YR AVG | N/A | 2.80% |